CLINICAL_TRIALS
trial_result
· 2025-04-27
Clinical Trial Update: Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD) [Phase 2, Phase 3]
Summary
A completed Phase 2/3 trial evaluating NRCT-101SR in adults with ADHD has posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neurocentria, Inc. | Conditions: ADHD | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-04-27